The complexity of integrins in cancer and new scopes for therapeutic targeting

British Journal of Cancer

Volumn 115, Issue 9, 2016, Pages 1017-1023

  Hamidi, Hellyeh ^a   Pietilä, Mika ^a   Ivaska, Johanna ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

cancer stem cells; endosomes; exosomes; focal adhesion kinase; growth factor receptors; integrins; tumour stroma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; INTEGRIN; SCATTER FACTOR RECEPTOR;

CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CELL MEMBRANE; HUMAN; NEOPLASM; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; EXPERIMENTAL THERAPY; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; TRENDS;

ANIMALS; HUMANS; INTEGRINS; MOLECULAR TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; THERAPIES, INVESTIGATIONAL; TUMOR MICROENVIRONMENT;

EID: 84989252405     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.312     Document Type: Review

References (45)

1. Alanko J, Mai A, Jacquemet G, Schauer K, Kaukonen R, Saari M, Goud B, Ivaska J. (2015). Integrin endosomal signalling suppresses anoikis. Nat Cell Biol 17: 1412-1421
2. Aslan B, Monroig P, Hsu MC, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han HD, Yuca E, Wu SY, Ivan C, Moss TJ, Ram PT, Wang H, Gol-Chambers A, Ozkayar O, Kanlikilicer P, Fuentes-Mattei E, Kahraman N, Pradeep S, Ozpolat B, Tucker S, Hung MC, Baggerly K, Bartholomeusz G, Calin G, Sood AK, Lopez-Berestein G. (2015). The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun 6: 7351
3. Barrow-McGee R, Kishi N, Joffre C, Menard L, Hervieu A, Bakhouche BA, Noval AJ, Mai A, Guzman C, Robert-Masson L, Iturrioz X, Hulit J, Brennan CH, Hart IR, Parker PJ, Ivaska J, Kermorgant S. (2016). Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes. Nat Commun 7: 11942
4. Bissell MJ, Hines WC. (2011). Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17: 320-329
5. Byron A, Frame MC. (2016). Adhesion protein networks reveal functions proximal and distal to cell-matrix contacts. Curr Opin Cell Biol 39: 93-100
6. Chen MB, Lamar JM, Li R, Hynes RO, Kamm RD. (2016). Elucidation of the roles of tumor integrin beta1 in the extravasation stage of the metastasis cascade. Cancer Res 76: 2513-2524
7. Chowdhury R, Webber JP, Gurney M, Mason MD, Tabi Z, Clayton A. (2015). Cancer exosomes trigger mesenchymal stem cell differentiation into pro-Angiogenic and pro-invasive myofibroblasts. Oncotarget 6: 715-731
8. Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ. (2011). Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 178: 1221-1232
9. Desgrosellier JS, Cheresh DA. (2010). Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9-22
10. Elez E, Kocakova I, Hohler T, Martens UM, Bokemeyer C, Van Cutsem E, Melichar B, Smakal M, Csoszi T, Topuzov E, Orlova R, Tjulandin S, Rivera F, Straub J, Bruns R, Quaratino S, Tabernero J. (2015). Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-Type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial. Ann Oncol 26: 132-140
11. Elosegui-Artola A, Bazellieres E, Allen MD, Andreu I, Oria R, Sunyer R, Gomm JJ, Marshall JF, Jones JL, Trepat X, Roca-Cusachs P. (2014). Rigidity sensing and adaptation through regulation of integrin types. Nat Mater 13: 631-637
12. Fedele C, Singh A, Zerlanko BJ, Iozzo RV, Languino LR. (2015). The alphavbeta6 integrin is transferred intercellularly via exosomes. J Biol Chem 290: 4545-4551
13. Fuste NP, Fernandez-Hernandez R, Cemeli T, Mirantes C, Pedraza N, Rafel M, Torres-Rosell J, Colomina N, Ferrezuelo F, Dolcet X, Gari E. (2016). Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin. Nat Commun 7: 11581
14. Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, Chen EI, Lyden D, Bissell MJ. (2013). The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15: 807-817
15. Goel HL, Pursell B, Chang C, Shaw LM, Mao J, Simin K, Kumar P, Vander Kooi CW, Shultz LD, Greiner DL, Norum JH, Toftgard R, Kuperwasser C, Mercurio AM. (2013). GLI1 regulates a novel neuropilin-2/alpha6beta1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol Med 5: 488-508
16. Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, Giancotti FG. (2006). Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126: 489-502
17. Hervy M, Hoffman L, Beckerle MC. (2006). From the membrane to the nucleus and back again: bifunctional focal adhesion proteins. Curr Opin Cell Biol 18: 524-532
18. Hirata E, Girotti MR, Viros A, Hooper S, Spencer-Dene B, Matsuda M, Larkin J, Marais R, Sahai E. (2015). Intravital imaging reveals how BRAF inhibition generates drug-Tolerant microenvironments with high integrin beta1/FAK signaling. Cancer Cell 27: 574-588
19. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D. (2015). Tumour exosome integrins determine organotropic metastasis. Nature 527: 329-335
20. Huang C, Park CC, Hilsenbeck SG, Ward R, Rimawi MF, Wang YC, Shou J, Bissell MJ, Osborne CK, Schiff R. (2011). beta1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib. Breast Cancer Res 13: R84
21. Ivaska J, Heino J. (2011). Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu Rev Cell Dev Biol 27: 291-320
22. Jacquemet G, Hamidi H, Ivaska J. (2015). Filopodia in cell adhesion, 3D migration and cancer cell invasion. Curr Opin Cell Biol 36: 23-31
23. Jiang H, Hegde S, Knolhoff BL, Zhu Y, Herndon JM, Meyer MA, Nywening TM, Hawkins WG, Shapiro IM, Weaver DT, Pachter JA, Wang-Gillam A, DeNardo DG. (2016). Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nat Med 22: 851-860
24. Kaukonen R, Mai A, Georgiadou M, Saari M, De Franceschi N, Betz T, Sihto H, Ventela S, Elo L, Jokitalo E, Westermarck J, Kellokumpu-Lehtinen PL, Joensuu H, Grenman R, Ivaska J. (2016). Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription. Nat Commun 7: 12237
25. Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS, Hill RC, Lakins JN, Schlaepfer DD, Mouw JK, LeBleu VS, Roy N, Novitskiy SV, Johansen JS, Poli V, Kalluri R, Iacobuzio-Donahue CA, Wood LD, Hebrok M, Hansen K, Moses HL, Weaver VM. (2016). Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med 22: 497-505
26. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN. (2010). Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6: 421-432
27. Lawson DA, Bhakta NR, Kessenbrock K, Prummel KD, Yu Y, Takai K, Zhou A, Eyob H, Balakrishnan S, Wang CY, Yaswen P, Goga A, Werb Z. (2015). Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature 526: 131-135
28. Legate KR, Wickstrom SA, Fassler R. (2009). Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev 23: 397-418
29. Lesniak D, Xu Y, Deschenes J, Lai R, Thoms J, Murray D, Gosh S, Mackey JR, Sabri S, Abdulkarim B. (2009). Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer. Cancer Res 69: 8620-8628
30. Lim ST. (2013). Nuclear FAK: a new mode of gene regulation from cellular adhesions. Mol Cells 36: 1-6
31. Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massague J. (2016). Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165: 45-60
32. Medema JP. (2013). Cancer stem cells: the challenges ahead. Nat Cell Biol 15: 338-344
33. Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR, Haider S, Brouilette K, Saha A, Vallath S, Bowen R, Chelala C, Eccles D, Tapper WJ, Thompson AM, Quinlan P, Jordan L, Gillett C, Brentnall A, Violette S, Weinreb PH, Kendrew J, Barry ST, Hart IR, Jones JL, Marshall JF. (2014). Therapeutic targeting of integrin alphavbeta6 in breast cancer. J Natl Cancer Inst 106: dju169
34. Muharram G, Sahgal P, Korpela T, De Franceschi N, Kaukonen R, Clark K, Tulasne D, Carpen O, Ivaska J. (2014). Tensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells. Dev Cell 29: 421-436
35. Nader GP, Ezratty EJ, Gundersen GG. (2016). FAK, talin and PIPKIgamma regulate endocytosed integrin activation to polarize focal adhesion assembly. Nat Cell Biol 18: 491-503
36. Navab R, Strumpf D, To C, Pasko E, Kim KS, Park CJ, Hai J, Liu J, Jonkman J, Barczyk M, Bandarchi B, Wang YH, Venkat K, Ibrahimov E, Pham NA, Ng C, Radulovich N, Zhu CQ, Pintilie M, Wang D, Lu A, Jurisica I, Walker GC, Gullberg D, Tsao MS. (2016). Integrin alpha11beta1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer. Oncogene 35: 1899-1908
37. Novitskaya V, Romanska H, Kordek R, Potemski P, Kusinska R, Parsons M, Odintsova E, Berditchevski F. (2014). Integrin alpha3beta1-CD151 complex regulates dimerization of ErbB2 via RhoA. Oncogene 33: 2779-2789
38. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E, Massague J. (2011). Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 17: 867-874
39. Oudin MJ, Jonas O, Kosciuk T, Broye LC, Guido BC, Wyckoff J, Riquelme D, Lamar JM, Asokan SB, Whittaker C, Ma D, Langer R, Cima MJ, Wisinski KB, Hynes RO, Lauffenburger DA, Keely PJ, Bear JE, Gertler FB. (2016). Tumor cell-driven extracellular matrix remodeling drives haptotaxis during metastatic progression. Cancer Discov 6: 516-531
40. Pickup MW, Mouw JK, Weaver VM. (2014). The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15: 1243-1253
41. Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. (2015). Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol 25: 234-240
42. Serrels A, Lund T, Serrels B, Byron A, McPherson RC, von Kriegsheim A, Gomez-Cuadrado L, Canel M, Muir M, Ring JE, Maniati E, Sims AH, Pachter JA, Brunton VG, Gilbert N, Anderton SM, Nibbs RJ, Frame MC. (2015). Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-Tumor immunity. Cell 163: 160-173
43. Shibue T, Brooks MW, Inan MF, Reinhardt F, Weinberg RA. (2012). The outgrowth of micrometastases is enabled by the formation of filopodiumlike protrusions. Cancer Discov 2: 706-721
44. Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, Lhermitte B, Pietsch T, Grujicic D, Steinbach JP, Wick W, Tarnawski R, Nam DH, Hau P, Weyerbrock A, Taphoorn MJ, Shen CC, Rao N, Thurzo L, Herrlinger U, Gupta T, Kortmann RD, Adamska K, McBain C, Brandes AA, Tonn JC, Schnell O, Wiegel T, Kim CY, Nabors LB, Reardon DA, van den Bent MJ, Hicking C, Markivskyy A, Picard M, Weller M. European Organisation for Research and Treatment of Cancer (EORTC), Canadian Brain Tumor Consortium, CENTRIC study team. (2014). Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 15: 1100-1108
45. Trusolino L, Bertotti A, Comoglio PM. (2001) A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107: 643-654